Trifork Group (TRIFOR) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
18 Aug, 2026Executive summary
Achieved 11% organic group growth (excluding hardware) and 21% improvement in adjusted EBITDA compared to Q2 2025, with continued momentum in both public and private sectors.
Products segment delivered 23% organic revenue growth (ex-hardware), now generating over half of group EBITDA and earnings, with strong AI integration and co-innovation with customers.
Public sector revenue grew 33% year-over-year, now representing 50% of total revenue, with significant growth in e-health and sovereign data solutions.
Strategic focus on digital health, financial services, public, aviation, and energy, with organizational changes to accelerate growth.
Strong momentum in managed solutions for data sovereignty and AI platforms, especially in regulated and data-sovereign environments.
Financial highlights
Q2 2026 revenue: EUR 58.2m, up 5.6% year-over-year; 6M 2026 revenue: EUR 114.3m; organic growth (excluding hardware) reached 11% in H1 2026.
Adjusted EBITDA margin improved to 10.8%, up 1.4 percentage points year-over-year; operational cash conversion at 90%.
Products generated 53% of group EBITDA in Q2 and 50% over the last 12 months, with product revenue at 37% of total in Q2.
Net debt-to-adjusted EBITDA at 1.1x, reflecting a strong balance sheet; net interest-bearing debt at EUR 34.8m.
EBIT Q2: EUR 2.2m (margin 3.8%), nearly doubled from EUR 1.1m (margin 2.1%) last year.
Outlook and guidance
Full-year 2026 guidance maintained: revenue EUR 230–240m (7–11% organic growth), adjusted EBITDA EUR 35–40m (16–33% growth, 15–17% margin).
Expect continued margin improvement as product business scales and services stabilize; anticipate higher margins in H2 2026, especially in services.
Focus for H2: securing more recurring contracts and expanding Infrastructure-as-a-Service offerings.
Hardware sales expected at least on par with 2025.
Latest events from Trifork Group
- 11% organic growth and 21% EBITDA rise, with Labs divestment and margin gains supporting outlook.TRIFOR
Q2 2026 - Q1 2026 saw 27% adjusted EBITDA growth and margin expansion, with 2026 guidance reaffirmed.TRIFOR
Q1 2026 - Q1 2026 delivered 8% organic growth, 27% EBITDA growth, and improved margins and guidance.TRIFOR
Q1 2026 - Revenue up 7.3% to EUR 220.9M, strong product growth, margin recovery, and robust outlook.TRIFOR
Q4 2025 - Record 2025 revenue, margin gains, and product-led growth set strong outlook for 2026.TRIFOR
Q4 2025 - Revenue and margins fell in 2024, triggering cost cuts; US and public sector drive growth.TRIFOR
Q3 2024 - Revenue and margins fell, but public sector wins and Labs gains support future optimism.TRIFOR
Q2 2024 - Q1 2025 delivered 14.1% revenue growth, margin gains, and strong Run segment expansion.TRIFOR
Q1 2025 - Record Q4 revenue, margin recovery, and US growth support 2025 expansion targets.TRIFOR
Q4 2024